A mid-sized self-funded employer covered GLP-1 medications for weight management, with Northwind’s clinical guardrails in place. Members lost an average of 31.8 pounds, and GLP-1 utilization held at 1% against a 6% national average.
A municipal utility with 2,600+ eligible members has run Northwind’s Diabetes Clinical Blueprint® since 2023. Its diabetes population grew, but its 2024 diabetes care costs were still lower than in 2022.
An 11,500-member self-funded employer eliminated $1.2M in unnecessary spend and enrolled 91.5% of eligible members in Northwind’s Diabetes Clinical Blueprint®.